Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct;10(10):1492-8.
doi: 10.1016/j.hrthm.2013.06.020. Epub 2013 Jun 26.

Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders

Frédéric Anselme  1 , Ghassan Moubarak, Arnaud Savouré, Bénédicte Godin, Bogdan Borz, Valérie Drouin-Garraud, Arnaud Gay
Affiliations

Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders

Frédéric Anselme et al. Heart Rhythm. 2013 Oct.

Abstract

Background: Sudden cardiac death is frequent in patients with lamin A/C gene (LMNA) mutations and may be related to ventricular arrhythmias (VA).

Objective: To evaluate a strategy of prophylactic implantable cardioverter-defibrillator (ICD) implantation in LMNA mutation carriers with significant cardiac conduction disorders.

Methods: Forty-seven consecutive patients (mean age 38 ± 11 years; 26 men) were prospectively enrolled between March 1999 and April 2009. Prophylactic ICD implantation was performed in patients with significant cardiac conduction disorders: patients requiring permanent pacing for bradycardia or already implanted with a pacemaker at the initial presentation, or patients with a PR interval of >0.24 seconds and either complete left bundle branch block or nonsustained ventricular tachycardia.

Results: Twenty-one (45%) patients had significant conduction disorders and received a prophylactic ICD. Among ICD recipients, no patient died suddenly and 11 (52%) patients required appropriate ICD therapy during a median follow-up of 62 months. Left ventricular ejection fraction was ≥45% in 9 patients at the time of the event. Among the 10 patients without malignant VA, device memory recorded nonsustained ventricular tachycardia in 8 (80%). The presence of significant conduction disorders was the only factor related to the occurrence of malignant VA (hazard ratio 5.20; 95% confidence interval 1.14-23.53; P = .03).

Conclusions: Life-threatening VAs are common in patients with LMNA mutations and significant cardiac conduction disorders, even if left ventricular ejection fraction is preserved. ICD is an effective treatment and should be considered in this patient population.

Keywords: ATP; AVB; Conduction disturbances; DCM; ICD; Implantable cardioverter-defibrillator; LBBB; LMNA; LVEF; Lamin A/C gene; NSVT; SCD; Sudden cardiac death; VA; VF; VT; Ventricular arrhythmias; antitachycardia pacing; atrioventricular block; dilated cardiomyopathy; implantable cardioverter-defibrillator; lamin A/C gene; left bundle branch block; left ventricular ejection fraction; nonsustained ventricular tachycardia; sudden cardiac death; ventricular arrhythmias; ventricular fibrillation; ventricular tachycardia.

PubMed Disclaimer

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

MeSH terms

LinkOut - more resources